Get the Weekly Intelligence Brief — top committee picks every Sunday.
NASDAQ · STOCK

Mettler Toledo

MTD Healthcare Unknown Updated July 31, 2026
$1,416.08
52W $1023.05 – $1525.17
51/100
$28.62B
31.8
1.24
AI Committee Verdict
Watch
Conviction: Moderate · 71% agreement · 7 analysts
+6.5%
-3.9%
1.66:1
Moderate

Is MTD Bullish or Bearish?

Mixed. Innellis AI committee rates Mettler Toledo (MTD) Watch with a composite score of 51/100 , based on 7 analysts with 71% agreement. Last updated July 31, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +9.45 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -10.55 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Growth Analyst sees a compelling case — 5 consecutive earnings beats -- consistent execution. Risk Analyst remains cautious — high leverage (debt-to-equity 81.23) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • ROE of 1675.8% shows genuine earnings power backing the valuation — Value
  • 5 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • P/E of 32.4 is moderate-to-rich — Value
  • Price-to-book of 1299.4x prices in significant intangible value — Value
  • Debt-to-equity of 81.23 adds balance-sheet risk to the value case — Value
  • RSI at 71 is in overbought territory — Technical
  • High leverage (debt-to-equity 81.23) amplifies downside in a stress scenario — Risk
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of July 31, 2026
Overall Committee Score
51/100
Agreement
71%
Analysts
7
Conviction
Moderate
Sector Rank
Top 83%
of 93 Healthcare peers
Value Analyst neutral
45 / 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 1675.8% shows genuine earnings power backing the valuation
− P/E of 32.4 is moderate-to-rich
Growth Analyst bullish
68 / 100 · High confidence
Strong, accelerating growth with consistent execution
+ 5 consecutive earnings beats -- consistent execution
Technical Analyst neutral
48 / 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− RSI at 71 is in overbought territory
Risk Analyst bearish
30 / 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 81.23) amplifies downside in a stress scenario
Macro Analyst neutral
58 / 100 · Moderate confidence
Macro backdrop is mixed or neutral -- not a strong tailwind or headwind either way
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst neutral
60 / 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2744.14)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 48.9 to 50.5.

Analyst-level changes:
  • Growth Analyst: stance neutral->bullish; score 52->68 (+17); +2 bullish signal(s).
  • Macro Analyst: stance bullish->neutral; score 65->58 (-8); +1 bullish signal(s).
  • Portfolio Manager: +2 bearish signal(s).
  • Technical Analyst: +1 bearish signal(s).
  • Value Analyst: +1 bearish signal(s).

Comparing 2026-07-30 to 2026-07-31 (1 day apart).

Technical Analysis

RSI (14)
77.4
Overbought
MACD Histogram
6.458
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Lh Ll
Support
$1360.33
Resistance
$1508.87
Bollinger %B
1.05
Above Upper Band
Price vs Moving Averages
EMA 9
$1,362.15 Above
EMA 21
$1,321.12 Above
EMA 50
$1,272.11 Above
EMA 200
$1,274.10 Above

Fundamental Analysis

Valuation
18
Growth
43
Profitability
1
Financial Health
13
Cash Flow
37
Valuation
P/E Ratio 31.8×
P/B Ratio
PEG Ratio 2.56
Dividend Yield 0.00%
52W High $1525.17
52W Low $1023.05
Quality & Growth
ROE -3677.4%
ROA 23.4%
Gross Margin 59.3%
Operating Margin 28.7%
Revenue Growth YoY
Debt / Equity
AI Fundamental Assessment
P/E ratio of 31.8 (rich relative to a 15-40x range); Price-to-book of 2222.4x; PEG ratio of 2.6 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -36.8%; Return on assets of 0.2%; Net margin of 0.2%; Gross margin of 0.6%; Current ratio of 1.12 (tight short-term liquidity); Debt-to-equity of 164.70; Free cash flow margin of 0.9% (thin cash generation); Free cash flow per share is positive (42.94); Most recent quarter beat estimates by 1.4%; 5 consecutive earnings beats; EPS growth decelerating (+0.0% -> -33.3% QoQ); Average YoY EPS growth of -11.7%; Analyst estimates falling over recent quarters
Get the Full MTD Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →

Explore MTD Further

📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime